You searched for "technology"
ANTS Imaging Competition 2024
Do you have an interest in ophthalmic imaging? Fancy capturing the anterior segment using a slit-lamp? Check out the new ANTS Imaging Competition.In conversation with Fares Antaki: The retinal age gap in schizophrenia
Fares Antaki. Nima Ghadiri (NG): The ‘retinal age gap’ (RAG) is a relatively new concept. Based on your study [1], how confident are you in proposing this as a non-invasive, accessible biomarker for accelerated biological ageing in patients with neuropsychiatric...Ocular electrophysiology
A 34-year-old woman, who is a CEO in a multinational firm, has been losing vision over the last 12 months. She has seen her opticians, who initially tried different glasses but could not improve things. Clinical examination is unremarkable. How...Contemporary glaucoma therapy: spoilt for choice
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...Rb-NET: a network to save life and preserve vision in children in Africa
Responding to need is a key element underpinning the VISION 2020 LINKS Programme [1]. It is embedded in the process through which LINKS are established, with institutions in low- and middle-income countries (LMICs) first defining their priority areas of training...Ellen aims to inspire a future focused on accessibility
Ellen Doherty, 47, who has macular degeneration due to Stargardt’s disease, became one of Scotland’s first Sight Loss Council volunteers earlier this year and is determined to inspire others to make accessibility a priority. Ellen and Callum Lancashire, Engagement Manager,...Treatment for cause of sudden sight loss now available through the NHS in England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...NICE approves treatment for cause of sudden sight loss
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...Michael Burdon to begin term of office as a BCPB Trustee
Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.British Council for Prevention of Blindness has a new Chairman
BCPB’s new Chairman Mr Michael Burdon FRCOphth FRCP is a consultant ophthalmologist at Queen Elizabeth Hospital Birmingham with a specialist interest in neuro-ophthalmology.
Development of testing protocols for high and low contrast visual acuity
Dysfunction of the afferent visual system, characterised by impairments in high-contrast visual acuity (HCVA) and low-contrast visual acuity (LCVA) have been demonstrated in some neurological conditions such as multiple sclerosis and Parkinson’s disease. HCVA and LCVA are also potential quantitative...
